Global Virology Specimen Collection Market is valued at approximately USD 5.00 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 1.00 % over the forecast period 2021-2027. Specimen collection is the process of obtaining tissue or fluids for laboratory analysis or near-patient testing. The Rising prevalence of viral diseases and emergence of newer pathogens, increasing geriatric population has led to the adoption of Virology Specimen Collection across the forecast period. For Instance: as per the Statista in March 2020, it was estimated that the infection rate for COVID-19 ranged between 1.5 and 3.5 infection rate per infected person. In comparison, the seasonal flu had an infection rate of 1.3. Also, with the technological advancements, the adoption & demand for Virology Specimen Collection is likely to increase the market growth during the forecast period. However, high cost of virology specimen collection technologies impedes the growth of the market over the forecast period of 2021-2027.
The key regions considered for the global Virology Specimen Collection market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing adoption of NAT (due to the high prevalence of TTIs), and the technological developments including portable diagnostics. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as rising disposable income, rising incidences of injuries and improving healthcare infrastructure would create lucrative growth prospects for the Virology Specimen Collection market across Asia-Pacific region.
Major market players included in this report are:
Puritan Medical Products Co.
Becton
Dickinson and Company (US)
Quidel Corporation (US)
Thermo Fisher Scientific Inc. (US)
Trinity Biotech (Ireland)
Titan Biotech Ltd. (India)
DiaSorin SA (Italy)
Vircell S.L. (Spain),
Copan Italia S.P.A (Italy),
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Blood Collection Kits
Specimen Collection Tubes
Viral Transport Media
Swabs
By Sample:
Blood Samples
Nasopharyngeal Samples
Throat Samples
Nasal Samples
Cervical Samples
Oral Samples
Other Samples
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027
Target Audience of the Global Virology Specimen Collection Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Companies Mentioned
Puritan Medical Products Co.
Becton
Dickinson and Company (US)
Quidel Corporation (US)
Thermo Fisher Scientific Inc. (US)
Trinity Biotech (Ireland)
Titan Biotech Ltd. (India)
DiaSorin SA (Italy)
Vircell S.L. (Spain),
Copan Italia S.P.A (Italy),